|
CLDN12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.34721181064424E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51150000188483E-08 |
| Normal-vs-Stage2 |
3.373900E-02 |
| Normal-vs-Stage3 |
2.916000E-02 |
| Normal-vs-Stage4 |
1.334310E-02 |
| Stage1-vs-Stage2 |
2.363200E-01 |
| Stage1-vs-Stage3 |
4.430600E-01 |
| Stage1-vs-Stage4 |
9.813800E-01 |
| Stage2-vs-Stage3 |
1.625400E-01 |
| Stage2-vs-Stage4 |
2.597400E-01 |
| Stage3-vs-Stage4 |
6.107600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.55110377267442E-11 |
| Normal-vs-AfricanAmerican |
3.124400E-03 |
| Normal-vs-Asian |
3.823400E-01 |
| Caucasian-vs-AfricanAmerican |
7.909400E-01 |
| Caucasian-vs-Asian |
3.560600E-01 |
| AfricanAmerican-vs-Asian |
5.770800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.71853675523926E-12 |
| Normal-vs-Female |
1.040270E-03 |
| Male-vs-Female |
6.936000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.223300E-03 |
| Normal-vs-Extreme_Weight |
1.9231199999914E-05 |
| Normal-vs-Obese |
4.756000E-04 |
| Normal-vs-Extreme_Obese |
7.491800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.472400E-01 |
| Normal_Weight-vs-Obese |
1.274600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.791400E-01 |
| Extreme_Weight-vs-Obese |
2.974000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.987600E-01 |
| Obese-vs-Extreme_Obese |
9.652000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.32710000000369E-06 |
| Normal-vs-Age(41-60Yrs) |
6.87250034658859E-10 |
| Normal-vs-Age(61-80Yrs) |
1.10249999996093E-06 |
| Normal-vs-Age(81-100Yrs) |
1.050030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.078600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.632200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.116000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.556200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.110400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.080400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.98330282489223E-14 |
| Normal-VS-Type2 PRCC |
5.022200E-03 |
| Normal-VS-KIRP CIMP |
4.826400E-02 |
| Normal-VS-Unclassified PRCC |
9.376600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.57480999999349E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.946000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.546010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.787200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.325600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.446400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.740500E-03 |
| Normal-vs-N1 |
1.710040E-02 |
| Normal-vs-N2 |
1.573640E-01 |
| N0-vs-N1 |
7.849800E-01 |
| N0-vs-N2 |
7.889600E-01 |
| N1-vs-N2 |
6.583200E-01 |
|
|
